Dr. Lal Path Labs Ltd.

Web: lalpathlabs.com NSE: LALPATHLAB BSE: 539524 SECTOR: Healthcare - Healthcare Services

1682 17(-1%)

Near 52W High of 1803

Volume

2L as on 22, Jul

Open

2,900

High

2,958

Low

2,931

1,699

VWAP

1,700

52 Week High

1,803

52 Week Low

1,273

Viand Research Rating

Quality Score

43/100

Growth Score

43/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

28,198

No. of Shares

16.8

P/E

57.13

P/B

12.01

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

21.01

ROCE

Profit Growth

Listing Date

23-Dec-15

Promoter Holding

53.21%

FII Holding

17.18%

DII Holding

21.37%

Price Chart

Price Performance

1 Week1%

1 Month2%

3 Months16%

6 Months20%

1 Year44%

YTD13%

Moving Average

5 Day SMA1,702

10 Day SMA1,708

20 Day SMA1,683

30 Day SMA1,666

50 Day SMA1,641

61 Day SMA1,617

80 Day SMA1,560

200 Day SMA1,716

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	1,744	1,708	1,729	1,757
Resistance 2	1,729	1,706	1,717	1,735
Resistance 1	1,714	1,703	1,710	1,727
Pivot Point	1,699	1,700	1,699	1,705
Support 1	1,684	1,697	1,687	1,697
Support 2	1,669	1,695	1,680	1,675
Support 3	1,655	1,692	1,669	1,668

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 53.21%	(0.01) 53.21%	(-0.61) 53.21%	(-0.11) 53.79%	(0.01) 53.91%	(0.01) 53.91%	(-0.71) 53.92%	(0.01) 54.60%	(0.01) 54.60%	(0.01) 54.60%	(-0.41) 54.61%	(0.01) 55.01%	(0.01) 55.03%	(0.01) 55.04%	(0.01) 55.04%	(-0.21) 55.05%	(0.01) 55.23%	(0.01) 55.23%	(0.01) 55.23%
FIIs	(-3.11) 17.18%	(-1.61) 20.29%	(0.21) 21.86%	(-2.21) 21.69%	(-2.91) 23.90%	(0.01) 26.82%	(1.41) 26.82%	(-0.71) 25.43%	(0.81) 26.15%	(1.01) 25.36%	(1.11) 24.35%	(-1.61) 23.27%	(-0.91) 24.89%	(2.51) 25.80%	(0.91) 23.26%	(-1.11) 22.37%	(-2.01) 23.44%	(-1.41) 25.45%	(0.01) 26.82%
DIIs	(2.21) 21.37%	(1.01) 19.20%	(0.61) 18.22%	(1.81) 17.62%	(2.91) 15.79%	(0.31) 12.88%	(0.21) 12.60%	(3.01) 12.42%	(0.11) 9.40%	(0.41) 9.27%	(0.51) 8.85%	(1.81) 8.34%	(0.41) 6.56%	(-0.11) 6.20%	(-0.31) 6.27%	(-0.31) 6.52%	(0.31) 6.83%	(0.81) 6.57%	(0.01) 5.73%
Government	0.01%	0.01%	0.27%	0.29%	0.29%	0.29%	0.29%	0.29%	0.29%	0.29%	0.29%	0.29%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	7.88%	6.94%	6.07%	6.22%	5.84%	5.82%	6.02%	6.95%	9.24%	10.12%	11.48%	12.65%	13.01%	12.38%	14.84%	15.46%	13.80%	12.01%	11.42%
No. of Shareholders	114,527	116,167	112,703	118,656	115,699	116,236	116,606	131,189	146,741	149,901	160,679	174,444	180,163	179,636	171,602	184,508	171,846	135,068	125,953

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	703	660	731	670	603	597	660	602	545	539	601	541	491	489	534	503	486	497	498	607
Sales Growth % (YoY)	16.6%	10.6%	10.7%	11.3%	10.5%	10.7%	9.8%	11.3%	11.1%	10.1%	12.6%	7.6%	1.1%	-1.5%	7.1%	-17.1%	12.6%	9.8%	15.4%	128%
Sales Growth % (QoQ)	6.5%	-9.7%	9.1%	11.1%	1%	-9.5%	9.6%	10.5%	1.1%	-10.3%	11.1%	10.2%	0.4%	-8.4%	6.2%	3.5%	-2.2%	-0.2%	-18%	-
Expenses	516	480	506	478	434	443	458	432	401	398	424	395	375	376	390	385	364	388	357	418
Operating Profit	187	179	224	192	169	154	202	170	145	141	178	146	116	113	144	118	121	109	142	189
OPM %	27	27	31	29	28	26	31	28	27	26	30	27	24	23	27	23	25	22	28	31
Other Income	24	-6	25	28	26	25	22	21	18	18	18	14	14	10	9	8	12	12	14	14
Interest	6	7	5	5	5	5	6	6	7	7	8	8	9	9	11	8	12	9	5	5
Depreciation	45	42	40	35	36	36	35	35	37	36	36	35	38	38	39	36	38	31	20	19
Profit before tax	160	124	204	181	153	138	183	150	120	116	152	118	83	76	103	81	84	82	131	179
Tax %	17	26	25	26	-1	29	29	28	28	29	27	29	32	30	30	28	26	29	26	25
Net Profit	132	91	152	134	156	98	131	108	86	82	111	84	57	54	72	58	62	58	96	134
Net Profit Growth % (QoQ)	45.1%	-40.1%	13.4%	-14.1%	59.2%	-25.2%	21.3%	25.6%	4.9%	-26.1%	32.1%	47.4%	5.6%	-25%	24.1%	-6.5%	6.9%	-39.6%	-28.4%	-
Net Profit Growth % (YoY)	-15.4%	-7.1%	16%	24.1%	81.4%	19.5%	18%	28.6%	50.9%	51.9%	54.2%	44.8%	-8.1%	-6.9%	-25%	-56.7%	-	-	-	-
TTM Net Profit	509	533	540	519	493	423	407	387	363	334	306	267	241	246	250	274	350	288	230	0
EPS in Rs	7.84	5.4	8.99	7.9	9.26	5.78	7.73	6.37	5.06	4.87	6.55	4.95	3.4	3.17	4.3	6.92	7.35	6.88	11.4	15.74

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	2763	2461	2227	2017	2087	1581	1330	1203	1057	912	791	660	558	452
Sales Growth %	12.2%	10.5%	10.4%	-3.4%	32%	18.9%	10.6%	13.9%	15.8%	15.3%	20%	18.2%	23.5%	32%
Expenses	1980	1764	1617	1527	1526	1145	987	910	793	675	582	504	419	354
Operating Profit	782	698	609	490	561	436	344	294	264	238	210	156	139	98
OPM %	28	28	27	24	27	28	26	24	25	26	26	24	25	22
Other Income	71	91	69	42	52	51	55	46	31	27	20	12	8	3
Interest	23	22	29	38	30	16	15	1	1	1	0	0	0	0
Depreciation	162	142	144	150	108	77	73	38	33	28	28	28	27	20
Profit before tax	669	625	505	344	475	394	310	301	261	237	201	140	119	80
Tax %	24	21	28	30	26	25	27	33	34	34	34	31	33	31
Net Profit	510	492	362	241	350	296	228	200	172	156	133	96	80	55
Net Profit Growth %	3.7%	35.9%	50.2%	-31.1%	18.2%	29.8%	14%	16.3%	10.3%	17.3%	38.5%	20%	45.5%	-
EPS in Rs	30.13	29.14	21.42	14.33	20.69	17.49	13.55	11.95	10.24	9.31	7.99	8.75	74.38	1643.22
Dividend Payout %	81	0	0	42	29	57	44	25	22	16	15	9	7	9

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	636	569	535	456	447	398	284	219	197	171	159	122	98	88
Cash from Investing Activity	-422	-303	-24	-287	-449	-212	-26	-100	-172	-137	-163	-113	-89	-64
Cash from Financing Activity	-264	-334	-414	-283	136	-139	-190	-55	13	-32	0	-1	-10	-15
Net Cash Flow	-50	-68	97	-114	134	48	67	64	37	2	-5	8	-2	9

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	168	84	84	84	83	83	83	83	83	83	83	83	83	55	54	3
Reserves	2341	2304	2089	1918	1766	1583	1418	1162	949	862	705	512	425	260	151	157
Borrowings	199	156	157	198	247	420	533	150	0	0	0	0	0	27	28	2
Other Liabilities	439	415	383	397	357	297	309	265	341	145	128	95	118	134	119	106
Total Liabilities	3146	2959	2713	2598	2454	2383	2343	1661	1374	1091	916	690	625	475	352	269
Fixed Assets	1257	1232	1168	1189	1228	1305	1369	447	413	209	208	152	166	150	140	127
CWIP	6	17	3	1	6	5	15	10	11	3	10	18	4	1	0	1
Investments	423	486	327	289	114	150	65	59	164	185	145	106	64	38	9	55
Other Assets	1461	1225	1215	1119	1107	923	893	1144	786	694	554	414	391	286	203	87
Total Assets	3146	2959	2713	2598	2454	2383	2343	1661	1374	1091	916	690	625	475	352	269

Delivery

#	Date	1500 20% 1803	Value (Cr)	Q/T 16	Del 44	Del 81
1	22-Jul	1699	31	5	60	18
2	21-Jul	1700	24	8	66	16
3	20-Jul	1693	36	9	60	21
4	17-Jul	1687	36	7	46	17
5	16-Jul	1733	36	7	58	21
6	15-Jul	1723	54	12	53	29
7	14-Jul	1745	50	10	58	29
8	13-Jul	1725	57	11	54	31
9	10-Jul	1693	35	11	60	21
10	9-Jul	1685	43	13	64	27
11	8-Jul	1654	31	9	46	14
12	7-Jul	1681	93	12	65	60
13	6-Jul	1686	134	17	78	104
14	3-Jul	1646	82	14	76	62
15	2-Jul	1650	40	9	58	23
16	1-Jul	1623	32	7	56	18
17	30-Jun	1646	70	12	59	42
18	29-Jun	1647	87	8	57	50
19	25-Jun	1689	44	10	63	28
20	24-Jun	1660	84	15	61	51
21	23-Jun	1670	30	8	56	17
22	22-Jun	1672	32	10	46	15
23	19-Jun	1636	37	13	51	19
24	18-Jun	1663	53	11	40	21
25	17-Jun	1652	107	18	21	23
26	16-Jun	1642	1498	27	10	155
27	15-Jun	1616	35	10	57	20
28	12-Jun	1602	31	9	57	18
29	11-Jun	1594	59	10	43	26
30	10-Jun	1569	29	5	60	18
31	9-Jun	1576	20	5	59	12
32	8-Jun	1546	53	10	45	24
33	5-Jun	1537	35	8	61	21
34	4-Jun	1561	29	8	56	16
35	3-Jun	1570	17	7	38	7
36	2-Jun	1561	25	7	59	15
37	1-Jun	1577	20	7	45	9
38	29-May	1607	67	10	65	44
39	27-May	1617	33	10	42	14
40	26-May	1604	75	21	56	42
41	25-May	1615	32	6	41	13
42	22-May	1630	32	6	59	19
43	21-May	1681	30	7	45	14
44	20-May	1669	37	10	36	13
45	19-May	1704	92	11	50	46
46	18-May	1646	78	8	56	44
47	15-May	1603	89	14	57	51
48	14-May	1600	41	11	49	20

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	28,198c	280c	0.98
22-Jul	28,478c	70c	0.25
21-Jul	28,549c	340c	1.21
17-Jul	28,208c	850c	2.92
16-Jul	29,058c	490c	1.66
15-Jul	29,548c	246c	0.84
14-Jul	29,301c	495c	1.72
13-Jul	28,807c	515c	1.82
10-Jul	28,292c	39c	0.14
09-Jul	28,331c	749c	2.72
08-Jul	27,581c	476c	1.70
07-Jul	28,058c	307c	1.08
06-Jul	28,364c	587c	2.11
02-Jul	27,778c	283c	1.03
30-Jun	27,494c	35c	0.13
29-Jun	27,459c	889c	3.13
26-Jun	28,348c	81c	0.28
25-Jun	28,267c	404c	1.45
24-Jun	27,863c	99c	0.35
23-Jun	27,962c	52c	0.19
22-Jun	28,014c	555c	2.02
19-Jun	27,459c	184c	0.67
17-Jun	27,644c	67c	0.24
16-Jun	27,576c	419c	1.54
15-Jun	27,157c	315c	1.17
12-Jun	26,842c	12c	0.04
11-Jun	26,854c	138c	0.51
10-Jun	26,716c	0	0

Stock Checklist

Price is above from 52 week high low average: 54%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView